01 / Vendor Profile
STANDARDS COORDINATING BODY FOR GENE, CELL, AND REGENERATIVE MEDICINES Federal Contracts and Awards
UEI D71MRJJYCVZ4 · CAGE 7XY82
Federal contract activity attributed to this vendor identity across FY 2019–FY 2025. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2019–FY 2025.
Across FY 2019–FY 2025, FPDS records attribute $1.09M in net contract obligations to STANDARDS COORDINATING BODY FOR GENE, CELL, AND REGENERATIVE MEDICINES across 8 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
STANDARDS COORDINATING BODY FOR GENE, CELL, AND REGENERATIVE MEDICINES contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2021 | $349.4K | 1 | 1 | — |
| FY 2022 | $359.4K | 3 | 1 | +2.9% |
| FY 2023 | $267.2K | 2 | 1 | −25.6% |
| FY 2024 | $115.5K | 2 | 1 | −56.8% |
04 / Federal Customers
Which federal agencies buy from STANDARDS COORDINATING BODY FOR GENE, CELL, AND REGENERATIVE MEDICINES?
Ranked by net obligations during FY 2019–FY 2025.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 1341 | $1.09M | 8 | 100.0% |
05 / Contracting Offices
Which contracting offices buy from STANDARDS COORDINATING BODY FOR GENE, CELL, AND REGENERATIVE MEDICINES?
Ranked by net obligations during FY 2019–FY 2025.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 1333ND | NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY | $1.09M | 8 | 100.0% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 813920 | PROFESSIONAL ORGANIZATIONS | $1.09M | 8 | 1 | 100.0% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| AJ12 | GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH | $1.09M | 8 | 1 | 100.0% |
08 / Competition Pattern
How was STANDARDS COORDINATING BODY FOR GENE, CELL, AND REGENERATIVE MEDICINES’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for STANDARDS COORDINATING BODY FOR GENE, CELL, AND REGENERATIVE MEDICINES?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 1333ND21PNB640152 | May 2, 2024 | $115.5K | NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY DEPT OF COMMERCE NIST | 813920 | AJ12 |
10 / Interpreting the Profile
How should you evaluate STANDARDS COORDINATING BODY FOR GENE, CELL, AND REGENERATIVE MEDICINES as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.